International Business Floats Perrigo Q2 Sales As Market Uncertainties Cloud Americas Region

OTC drug private label/store brand giant reports April-June overall net sales of $981m, up 3.4%. As its Americas business organic sales slipped 1.4% to $622m, international business sales grew 11.7% to $359m.

• Source: Alamy

The good news from Perrigo Company PLC’s latest quarter is its international consumer health business wasn’t a drag on its overall results.

The bad news from the firm’s second-quarter results is that its normally reliable sales driver, the Americas region consumer business, struggled due to causes directly and indirectly related to COVID-19 and a turnaround for the segment isn’t assured

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Earnings

More from Business